Estrella Immunopharma changes fiscal year to June 30, effective Sept 29, 2023

Estrella Immunopharma, Inc.

Fiscal year end changed from December 31 to June 30, effective upon close of business combination.
Change aligns fiscal year with Estrella Biopharma, the accounting acquirer in the combination.
First fiscal year under new end will be the period ending June 30, 2024.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Estrella Immunopharma, Inc.: Fiscal year end changed from December 31 to June 30 effective as of the closing date of the Business Combination (effective 2023-09-29).

Change: fiscal year change
Effective: 2023-09-29

Exact text from the filing

Effective as of the closing date of the Business Combination on September 29, 2023, the Company’s fiscal year end changed from December 31 to June 30.

View on SEC.gov

Browse all governance changes →

Estrella Immunopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-087115

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.